ProgenityLogo.jpg
Progenity to Participate in Crohn’s & Colitis Foundation’s Fourth Annual IBD Innovate Conference
October 19, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the fourth annual IBD Innovate...
ProgenityLogo.jpg
Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Ingestible Therapeutics Technologies
October 13, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has...
ProgenityLogo.jpg
Progenity Announces Closing of $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq Rules
October 06, 2021 16:02 ET | Progenity, Inc.
SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced registered...
ProgenityLogo.jpg
Progenity Announces $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq Rules
October 04, 2021 13:40 ET | Progenity, Inc.
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive agreement with...
ProgenityLogo.jpg
Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
September 21, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11th annual Partnership...
ProgenityLogo.jpg
Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test
September 14, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has...
ProgenityLogo.jpg
Progenity to Participate in Two Upcoming Investor Conferences
September 03, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in two upcoming virtual investor...
ProgenityLogo.jpg
Progenity Announces Closing of $40 Million Underwritten Public Offering
August 24, 2021 16:05 ET | Progenity, Inc.
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced underwritten...
ProgenityLogo.jpg
Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants
August 19, 2021 22:20 ET | Progenity, Inc.
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the pricing of its previously announced underwritten...
ProgenityLogo.jpg
Progenity Announces Proposed Underwritten Public Offering of Common Stock and Warrants
August 19, 2021 16:05 ET | Progenity, Inc.
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, announced today that it intends to offer and sell, subject to market...